171 related articles for article (PubMed ID: 36576549)
41. Preoperative concurrent chemoradiotherapy MRI characteristics favouring pathologic complete response in patients with rectal cancer: Usefulness of MR T2-stage as an ancillary finding for predicting pathologic complete response.
Lee HJ; Chung WS; An JH; Kim JH
J Med Imaging Radiat Oncol; 2021 Apr; 65(2):166-174. PubMed ID: 33319450
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic performance of short noncontrast biparametric 3-T MRI for tonsillar infections: comparison with a full protocol including contrast-enhanced sequences.
Vierula JP; Nurminen J; Jussila V; Nyman M; Heikkinen J; Pape B; Sorvettula K; Mattila K; Hirvonen J
Eur Radiol Exp; 2023 Oct; 7(1):65. PubMed ID: 37872406
[TBL] [Abstract][Full Text] [Related]
43. Split scar sign to predict complete response in rectal cancer after neoadjuvant chemoradiotherapy: systematic review and meta-analysis.
Torri GB; Wiethan CP; Langer FW; de Oliveira GS; Meirelles AVB; Horvat N; Tse JR; Dias AB; Altmayer S
Eur Radiol; 2024 Jun; 34(6):3874-3881. PubMed ID: 37979009
[TBL] [Abstract][Full Text] [Related]
44. [Combined T2-weighted and diffusion-weighted MR imaging for staging of rectal cancers].
Zhang CD; Zhang HM; Meng YK; Ye F; Jiang J; Ouyang H; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):46-51. PubMed ID: 29365417
[No Abstract] [Full Text] [Related]
45. Reduced field-of-view versus full field-of-view diffusion-weighted imaging for the evaluation of complete response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
Jang S; Lee JM; Yoon JH; Bae JS
Abdom Radiol (NY); 2021 Apr; 46(4):1468-1477. PubMed ID: 32986174
[TBL] [Abstract][Full Text] [Related]
46. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
47. MRI tumour regression grade in locally recurrent rectal cancer.
Voogt ELK; Nordkamp S; van Zoggel DMGI; Daniëls-Gooszen AW; Nieuwenhuijzen GAP; Bloemen JG; Creemers GJ; Cnossen JS; van Lijnschoten G; Burger JWA; Rutten HJT; Nederend J
BJS Open; 2022 May; 6(3):. PubMed ID: 35552373
[TBL] [Abstract][Full Text] [Related]
48. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer.
Gollub MJ; Blazic I; Felder S; Knezevic A; Gonen M; Garcia-Aguilar J; Paty PP; Smith JJ
Eur Radiol; 2019 Mar; 29(3):1104-1113. PubMed ID: 30242504
[TBL] [Abstract][Full Text] [Related]
49. Integrated slice-specific dynamic shimming diffusion weighted imaging (DWI) for rectal Cancer detection and characterization.
Qiu J; Liu J; Bi Z; Sun X; Wang X; Zhang J; Liu C; Zhu J; Qin N
Cancer Imaging; 2021 Apr; 21(1):32. PubMed ID: 33827704
[TBL] [Abstract][Full Text] [Related]
50. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
[TBL] [Abstract][Full Text] [Related]
51. Comparison of reduced field-of-view diffusion-weighted imaging (DWI) and conventional DWI techniques in the assessment of rectal carcinoma at 3.0T: Image quality and histological T staging.
Peng Y; Li Z; Tang H; Wang Y; Hu X; Shen Y; Hu D
J Magn Reson Imaging; 2018 Apr; 47(4):967-975. PubMed ID: 28691219
[TBL] [Abstract][Full Text] [Related]
52. Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer.
Chandramohan A; Siddiqi UM; Mittal R; Eapen A; Jesudason MR; Ram TS; Singh A; Masih D
Eur J Radiol Open; 2020; 7():100223. PubMed ID: 32140502
[TBL] [Abstract][Full Text] [Related]
53. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of Tumor Volume, Tumor Volume Reduction Rate and Magnetic Resonance Tumor Regression Grade in Rectal Cancer.
Pikūnienė I; Strakšytė V; Basevičius A; Žilinskas J; Ambrazienė R; Jančiauskienė R; Saladžinskas Ž
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138297
[No Abstract] [Full Text] [Related]
55. Evaluation of a multiparametric MRI scoring system for histopathologic treatment response following preoperative chemoradiotherapy for rectal cancer.
Khwaja SA; Thipphavong S; Kirsch R; Menezes RJ; Kennedy ED; Brierley JD; Jhaveri KS
Eur J Radiol; 2021 May; 138():109628. PubMed ID: 33721764
[TBL] [Abstract][Full Text] [Related]
56. Comparison of T2-weighted and diffusion-weighted imaging for the diagnosis of placenta accreta spectrum abnormality.
Prakash A; Kumar I; Verma A; Shukla RC
Acta Radiol; 2023 Apr; 64(4):1694-1701. PubMed ID: 36373565
[TBL] [Abstract][Full Text] [Related]
57. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
Delli Pizzi A; Mastrodicasa D; Marchioni M; Primiceri G; Di Fabio F; Cianci R; Seccia B; Sessa B; Mincuzzi E; Romanelli M; Castellan P; Castellucci R; Colasante A; Schips L; Basilico R; Caulo M
Eur Radiol; 2021 Jun; 31(6):3874-3883. PubMed ID: 33211143
[TBL] [Abstract][Full Text] [Related]
58. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy.
Napoletano M; Mazzucca D; Prosperi E; Aisa MC; Lupattelli M; Aristei C; Scialpi M
Abdom Radiol (NY); 2019 Nov; 44(11):3664-3673. PubMed ID: 31004202
[TBL] [Abstract][Full Text] [Related]
59. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG).
Siddiqui MR; Gormly KL; Bhoday J; Balyansikova S; Battersby NJ; Chand M; Rao S; Tekkis P; Abulafi AM; Brown G
Clin Radiol; 2016 Sep; 71(9):854-62. PubMed ID: 27381221
[TBL] [Abstract][Full Text] [Related]
60. MRI Evaluation of Complete and Near-Complete Response after Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.
Popita AR; Lisencu C; Rusu A; Popita C; Cainap C; Irimie A; Resiga L; Munteanu A; Fekete Z; Badea R
Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453969
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
